hotspot -WSS

hotspot

author：fashion 2025-10-01 22:16:26 - browse：196

Adobe

LONDON — Merck said Wednesday it is buying ophthalmology-focused startup EyeBio in a deal worth up to $3 billion, as the pharma company looks to diversify its pipeline.

Under the deal, Merck, through a subsidiary, will pay $1.3 billion in cash upfront, with another $1.7 billion potentially included if certain regulatory and commercial milestones are met. The Wall Street Journal first reported the news Tuesday night.

EyeBio has been developing a drug called restoret for a number of retinal diseases, including age-related macular degeneration and diabetic macular edema. It presented data in February from a Phase 1/2 trial of restoret in both conditions. Merck said it plans to move restoret into a pivotal trial for diabetic macular edema later this year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： 5 important ways Henrietta Lacks changed medical science

WSS

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Breakthrough Alzheimer’s drugs are inaccessible in rural states

NIH launches clinical trials and new research office for long Covid

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

No plane should take off without an EpiPen onboard

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

1 dead, 9 hurt in July 4th fireworks explosion

Guidelines to prevent youth baseball injuries need more muscle

Vertex non

United colonoscopy coverage change 'may cost lives,' doctors say

Wildfire pollution widens asthma inequities on Long Island

Psychedelics group wrestles with new pharma identity

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

Guidelines to prevent youth baseball injuries need more muscle

Noem? Reynolds? A very early look at the Republican 'veepstakes'

explore

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

EQRx, failed developer of low

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Greece's new parliament sworn in following conservative party's election victory

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

New safety details link Apellis eye drug to rare cases of blindness

leisure time

knowledge

hotspot

hotspot